Autek China Inc
SZSE:300595

Watchlist Manager
Autek China Inc Logo
Autek China Inc
SZSE:300595
Watchlist
Price: 17.23 CNY
Market Cap: 15.4B CNY
Have any thoughts about
Autek China Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one Autek China Inc stock under the Base Case scenario is 21.83 CNY. Compared to the current market price of 17.23 CNY, Autek China Inc is Undervalued by 21%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
21.83 CNY
Undervaluation 21%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.4
P/S
P/S
Price to Sales
8.4
vs History
85
vs Industry
16
Median 3Y
16.7
Median 5Y
24.6
Industry
2.3
Forward
7.7
More Details
23.7
P/E
P/E
Price to Earnings
23.7
vs History
85
vs Industry
26
Median 3Y
40
Median 5Y
59.6
Industry
23
Forward
21.4
More Details
22.2
P/OCF
P/OCF
Price to OCF
22.2
vs History
84
vs Industry
20
Median 3Y
38.4
Median 5Y
53.3
Industry
14.3
More Details
31.4
P/FCFE
P/FCFE
Price to FCFE
31.4
vs History
84
vs Industry
19
Median 3Y
49.4
Median 5Y
66.7
Industry
20
More Details
3.5
P/B
P/B
Price to Book Value
3.5
vs History
85
vs Industry
25
Median 3Y
6.1
Median 5Y
12.9
Industry
2.2
More Details
6.8
EV/S
EV/S
Enterprise Value to Sales
6.8
vs History
88
vs Industry
18
Median 3Y
14.7
Median 5Y
23.5
Industry
2.4
Forward
6.3
More Details
9.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.4
vs History
88
vs Industry
24
Median 3Y
19.5
Median 5Y
30.7
Industry
5
More Details
17.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.1
vs History
85
vs Industry
23
Median 3Y
31.8
Median 5Y
50.8
Industry
12.9
Forward
13.9
More Details
17.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
17.1
vs History
85
vs Industry
29
Median 3Y
31.8
Median 5Y
50.8
Industry
17.4
Forward
15.4
More Details
18.1
EV/OCF
EV/OCF
Enterprise Value to OCF
18.1
vs History
84
vs Industry
25
Median 3Y
33.9
Median 5Y
49.8
Industry
14
More Details
25.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
25.7
vs History
84
vs Industry
20
Median 3Y
44.3
Median 5Y
63
Industry
18.2
More Details
5.1
EV/IC
EV/IC
Enterprise Value to IC
5.1
vs History
85
vs Industry
17
Median 3Y
9.4
Median 5Y
17.1
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Autek China Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Autek China Inc
SZSE:300595
15.5B CNY 8.4 23.7 17.1 17.1
JP
Hoya Corp
TSE:7741
6.8T JPY 8.3 34.8 22.9 27.6
CH
Alcon AG
SIX:ALC
37.8B CHF 4.3 36 17.7 34.3
DK
Coloplast A/S
CSE:COLO B
175.9B DKK 6.5 34.8 22.4 26.4
US
Align Technology Inc
NASDAQ:ALGN
16.3B USD 4.1 37 18.7 22.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
52.2B CNY 11.8 28.2 24.5 24.5
KR
HLB Inc
KOSDAQ:028300
10.1T KRW 194.6 -54.4 -83.7 -79
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD 4.4 15.3 10.5 11.9
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.4 -17.3 16.7 55.9
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 2.6 37.1 266.5 465.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.2 46.6 23.2 38.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Autek China Inc
SZSE:300595
Average EV/EBITDA: 44
17.1
17%
1
JP
Hoya Corp
TSE:7741
22.9
15%
1.5
CH
Alcon AG
SIX:ALC
17.7
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.4
11%
2
US
Align Technology Inc
NASDAQ:ALGN
18.7
15%
1.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.5
27%
0.9
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -83.7 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.5
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.7
22%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
266.5
12%
22.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.2
22%
1.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 214,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.